The serine threonine kinase RIP3: Lost and found

BMB Reports

Volumn 48, Issue 6, 2015, Pages 303-312

  Morgan, Michael J ^a   Kim, You Sun ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Ajou University School of Medicine   (South Korea)

Author keywords

Hypomethylating agents; Programmed necrosis; RIP3 (RIPK3)

Indexed keywords

RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK3 PROTEIN, HUMAN;

ANIMAL; CELL DEATH; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; METHYLATION; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CELL DEATH; CELL LINE, TUMOR; GENE EXPRESSION; HUMANS; METHYLATION; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES;

EID: 84936105624     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2015.48.6.068     Document Type: Review

References (73)

1. Vandenabeele P, Galluzzi L, Vanden Berghe T and Kroemer G (2010) Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11, 700-714
2. Vanlangenakker N, Vanden Berghe T and Vandenabeele P (2012) Many stimuli pull the necrotic trigger, an overview. Cell Death Differ 19, 75-86
3. Morgan M and Liu Z (2013) Programmed cell death with a necrotic-like phenotype. Biomol Concepts 4, 259-275
4. Kroemer G, El-Deiry WS, Golstein P et al (2005) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 12 Suppl 2, 1463-1467
5. Fiers W, Beyaert R, Declercq W and Vandenabeele P (1999) More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene 18, 7719-7730
6. Moriwaki K and Chan FKM (2013) RIP3: a molecular switch for necrosis and inflammation. Genes Dev 27, 1640-1649
7. Linkermann A, Brasen JH, Darding M et al (2013) Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc Nat Acad Sci U S A 110, 12024-12029
8. Kaiser WJ, Upton JW and Mocarski ES (2013) Viral modulation of programmed necrosis. Curr Opin Virol 3, 296-306
9. Ofengeim D, Ito Y, Najafov A et al (2015) Activation of Necroptosis in Multiple Sclerosis. Cell Rep 10, 1836-1849
10. Lin Y, Choksi S, Shen HM et al (2004) Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. J Biol Chem 279, 10822-10828
11. Holler N, Zaru R, Micheau O et al (2000) Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 1, 489-495
12. Morgan MJ and Liu ZG (2010) Reactive oxygen species in TNFalpha-induced signaling and cell death. Mol Cells 30, 1-12
13. Devin A, Lin Y and Liu ZG (2003) The role of the deathdomain kinase RIP in tumour-necrosis-factor-induced activation of mitogen-activated protein kinases. EMBO Rep 4, 623-627
14. Degterev A, Hitomi J, Germscheid M et al (2008) Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4, 313-321
15. Chan FK, Shisler J, Bixby JG et al (2003) A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J Biol Chem 278, 51613-51621
16. Degterev A, Huang Z, Boyce M et al (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1, 112-119
17. Cho YS, Challa S, Moquin D et al (2009) Phosphorylationdriven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137, 1112-1123
18. He S, Wang L, Miao L et al (2009) Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137, 1100-1111
19. Zhang DW, Shao J, Lin J et al (2009) RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325, 332-336
20. Sun X, Yin J, Starovasnik MA, Fairbrother WJ and Dixit VM (2002) Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3. J Biol Chem 277, 9505-9511
21. Li J, McQuade T, Siemer AB et al (2012) The RIP1/RIP3 Necrosome Forms a Functional Amyloid Signaling Complex Required for Programmed Necrosis. Cell 150, 339-350
22. Rickard JA, O'Donnell JA, Evans JM et al (2014) RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 157, 1175-1188
23. Dillon CP, Weinlich R, Rodriguez DA et al (2014) RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 157, 1189-1202
24. Orozco S, Yatim N, Werner MR et al (2014) RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis. Cell Death Differ 21, 1511-1521
25. Dannappel M, Vlantis K, Kumari S et al (2014) RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 513, 90-94
26. Zhao J, Jitkaew S, Cai Z et al (2012) Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci U S A 109, 5322-5327
27. Sun L, Wang H, Wang Z et al (2012) Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148, 213-227
28. Wu JF, Huang Z, Ren JM et al (2013) Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res 23, 994-1006
29. Murphy JM, Czabotar PE, Hildebrand JM et al (2013) The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39, 443-453
30. Wang HY, Sun LM, Su LJ et al (2014) Mixed Lineage Kinase Domain-like Protein MLKL Causes Necrotic Membrane Disruption upon Phosphorylation by RIP3. Mol Cell 54, 133-146
31. Cai ZY, Jitkaew S, Zhao J et al (2014) Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol 16, 55-56
32. Chen X, Li WJ, Ren JM et al (2014) Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res 24, 105-121
33. Dondelinger Y, Declercq W, Montessuit S et al (2014) MLKL Compromises Plasma Membrane Integrity by Binding to Phosphatidylinositol Phosphates. Cell Rep 7, 971-981
34. Hildebrand JM, Tanzer MC, Lucet IS et al (2014) Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death. Proc Natl Acad Sci U S A 111, 15072-15077
35. Cook WD, Moujalled DM, Ralph TJ et al (2014) RIPK1-and RIPK3-induced cell death mode is determined by target availability. Cell Death Differ 21, 1600-1612
36. Bonnet MC, Preukschat D, Welz PS et al (2011) The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation. Immunity 35, 572-582
37. Ch'en IL, Tsau JS, Molkentin JD, Komatsu M and Hedrick SM (2011) Mechanisms of necroptosis in T cells. J Exp Med 208, 633-641
38. Dillon CP, Oberst A, Weinlich R et al (2012) Survival function of the FADD-CASPASE-8-cFLIP(L) complex. Cell Rep 1, 401-407
39. Kaiser WJ, Upton JW, Long AB et al (2011) RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471, 368-372
40. Lu JV, Weist BM, van Raam BJ et al (2011) Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity. Proc Natl Acad Sci U S A 108, 15312-15317
41. Moulin M, Anderton H, Voss AK et al (2012) IAPs limit activation of RIP kinases by TNF receptor 1 during development. EMBO J 31, 1679-1691
42. Oberst A, Dillon CP, Weinlich R et al (2011) Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471, 363-367
43. Zhang HB, Zhou XH, McQuade T, Li JH, Chan FKM and Zhang JK (2011) Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 471, 373-376
44. Vercammen D, Beyaert R, Denecker G et al (1998) Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 187, 1477-1485
45. Lin Y, Devin A, Rodriguez Y and Liu ZG (1999) Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev 13, 2514-2526
46. Feng S, Yang Y, Mei Y et al (2007) Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. Cell Signal 19, 2056-2067
47. O'Donnell MA, Perez-Jimenez E, Oberst A et al (2011) Caspase 8 inhibits programmed necrosis by processing CYLD. Nat Cell Biol 13, 1437-1442
48. Lu JV, Weist BM, van Raam BJ et al (2011) Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity. Proc Nat Acad Sci U S A 108, 15312-15317
49. Gunther C, Martini E, Wittkopf N et al (2011) Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis. Nature 477, 335-U108
50. Welz PS, Wullaert A, Vlantis K et al (2011) FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 477, 330-U102
51. Grooten J, Goossens V, Vanhaesebroeck B and Fiers W (1993) Cell membrane permeabilization and cellular collapse, followed by loss of dehydrogenase activity: early events in tumour necrosis factor-induced cytotoxicity. Cytokine 5, 546-555
52. Laster SM, Wood JG and Gooding LR (1988) Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J Immunol 141, 2629-2634
53. Denecker G, Vercammen D, Steemans M et al (2001) Death receptor-induced apoptotic and necrotic cell death: differential role of caspases and mitochondria. Cell Death Differ 8, 829-840
54. Sakon S, Xue X, Takekawa M et al (2003) NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J 22, 3898-3909
55. Yu PW, Huang BCB, Shen M et al (1999) Identification of RIP3, a RIP-like kinase that activates apoptosis and NF kappa B. Curr Biol 9, 539-542
56. Sun XQ, Lee J, Navas T, Baldwin DT, Stewart TA and Dixit VM (1999) RIP3, a novel apoptosis-inducing kinase. J Biol Chem 274, 16871-16875
57. Kasof GM, Prosser JC, Liu DR, Lorenzi MV and Gomes BC (2000) The RIP-like kinase, RIP3, induces apoptosis and NF-kappa B nuclear translocation and localizes to mitochondria. FEBS Lett 473, 285-291
58. Koo G-B, Morgan MJ, Lee D-G et al (2015) Methylation-Dependent Loss of RIP3 Expression in Cancer Represses Programmed Necrosis in Response to Chemotherapeutics. Cell Res 25, 707-725
59. Yang Y, Hu W, Feng S, Ma J and Wu M (2005) RIP3 beta and RIP3 gamma, two novel splice variants of receptor-interacting protein 3 (RIP3), downregulate RIP3-induced apoptosis. Biochem Biophys Res Commun 332, 181-187
60. Newton K, Sun XQ and Dixit VM (2004) Kinase RIP3 is dispensable for normal NF-KBs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and toll-like receptors 2 and 4. Mol Cell Biol 24, 1464-1469
61. Hanahan D and Weinberg RA (2011) Hallmarks of Cancer: The Next Generation. Cell 144, 646-674
62. Nugues AL, El Bouazzati H, Hetuin D et al (2014) RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage. Cell Death Dis 5, e1384
63. Liu XY, Lai F, Yan XG et al (2015) RIP1 Kinase Is an Oncogenic Driver in Melanoma. Cancer Res 75, 1736-1748
64. Fukasawa M, Kimura M, Morita S et al (2006) Microarray analysis of promoter methylation in lung cancers. J Hum Genet 51, 368-374
65. Zong WX, Ditsworth D, Bauer DE, Wang ZQ and Thompson CB (2004) Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev 18, 1272-1282
66. David KK, Andrabi SA, Dawson TM and Dawson VL (2009) Parthanatos, a messenger of death. Front Biosci 14, 1116-1128
67. Sosna J, Voigt S, Mathieu S et al (2014) TNF-induced necroptosis and PARP-1-mediated necrosis represent distinct routes to programmed necrotic cell death. Cell Mol Life Sci 71, 331-348
68. Tenev T, Bianchi K, Darding M et al (2011) The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPs. Mol Cell 43, 432-448
69. Feoktistova M, Geserick P, Kellert B et al (2011) cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms. Mol Cell 43, 449-463
70. Biton S and Ashkenazi A (2011) NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-alpha feedforward signaling. Cell 145, 92-103
71. Li JX, Feng JM, Wang Y et al (2014) The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury. Cell Death Dis 5, e1278
72. Kim SK, Kim WJ, Yoon JH et al (2015) Upregulated RIP3 Expression Potentiates MLKL Phosphorylation-Mediated Programmed Necrosis in Toxic Epidermal Necrolysis. J Invest Dermatol [Epub ahead of print]
73. Motani K, Kushiyama H, Imamura R, Kinoshita T, Nishiuchi T and Suda T (2011) Caspase-1 Protein Induces Apoptosis-associated Speck-like Protein Containing a Caspase Recruitment Domain (ASC)mediated Necrosis Independently of Its Catalytic Activity. J Biol Chem 286, 33963-33972